• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quintiles, IMS collaborate on real-world evidence

Quintiles, IMS collaborate on real-world evidence

October 22, 2015
CenterWatch Staff

Global CRO Quintiles and IMS Health, a global information and technology services company, have announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. Offering complementary strengths in real-world data management, operational delivery, advanced analytics and scientific and therapeutic expertise, the collaboration is designed to accelerate assessments of treatment impact and help improve patient outcomes.

As healthcare stakeholders increase their focus on value, evidence of a medicine’s effectiveness and safety in real-world settings continues to be a critical component of drug development and healthcare delivery. The new alliance brings together market-leading capabilities in prospective and retrospective research, operational study delivery, proprietary RWE technologies and epidemiological expertise to provide customers with a complete view of a product’s impact and the patient experience in clinical practice.

“As demand increases for real-world evidence, biopharmaceutical companies need to integrate data from multiple sources to accelerate critical insights for stakeholders,” said Scott Evangelista, president of integrated healthcare services at Quintiles. “This collaboration greatly enhances access to healthcare data from across the world—providing customers with the critical information and the related services needed to demonstrate the value of their medicines to physicians, payers and patients.”

The alliance will combine IMS Health’s strength in technology-enabled RWE information management, deep understanding of global health systems and advanced clinical and commercial analytics with Quintiles’ global breadth of operational expertise, experience in prospective studies and scientific knowledge to support all aspects of real-world and late-phase research.

Healthcare stakeholders will benefit from IMS Health’s access to 500 million anonymous patient records, as well as its scalable Evidence 360 RWE platform. Quintiles is providing experience in real-world and late-phase programs involving more than 74,000 sites and more than 650,000 enrolled patients in more than 100 countries since 2011 along with its award-winning Quintiles Infosario platform. Applying those combined strengths will enable biopharmaceutical companies to optimize physician and patient recruitment, streamline data collection and study execution, as well as improve the quality and impact of real-world evidence worldwide.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing